A new report has been published by Transparency Market Research, titled, “Acute Kidney Injury Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.” As per the report, the global acute kidney injury treatment market was valued at US$ 1,351.70 Mn in 2018 and is anticipated to expand at a CAGR of more than 7% during the forecast period.

The TMR report anticipates that the rise in the geriatric population and increasing incidences of acute kidney injuries will propel that the global market during the forecast period. Region-wise, North America is projected to be a dominant region in the global market, due to the increase in the patient population, high geriatric population, and rising technological advancements. On the other hand, the acute kidney injury treatment market in Asia Pacific is projected to expand at a CAGR of around 8% during the forecast period, owing to the rising geriatric population, growing healthcare infrastructure, and increasing patient population in the region.
Additionally, research and development activities and initiatives by governments in the healthcare sector are further expected to enhance the market in Asia Pacific region. Moreover, extensive government initiatives in the healthcare sector, increasing research and development, and growing presence and investments by global prime players in the Asia pacific region market are the factors responsible for the rapid growth of Asia Pacific in the global acute kidney injury treatment market

To request a brochure of the global acute kidney injury treatment market, kindly fill the form - http://bit.ly/2F0HAdZ

In accordance with the type, the TMR report states that the prerenal acute kidney injury segment dominated the global acute kidney injury treatment market in 2018 and it is projected to gain market share by the end of 2027, and expand at a CAGR of around 7.5% during the forecast period. As per the report, prerenal acute kidney injuries constitute 55%-65% cases of acute kidney injury cases, while intrinsic acute kidney injuries account for 25%-30% share. Around 5%-10% cases are of postrenal acute kidney injuries. Additionally, factors such as increasing numbers of key players operating in the market and their rising number of acquisitions, mergers, and collaborations, growing government approvals for new products, coupled with the increasing adoption of advanced products will further fuel the growth of the acute kidney injury treatment market in North America.

About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Mail – [email protected]